Compare FLGT & EOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FLGT | EOI |
|---|---|---|
| Founded | 2011 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 697.3M | 805.7M |
| IPO Year | 2016 | N/A |
| Metric | FLGT | EOI |
|---|---|---|
| Price | $26.96 | $19.83 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $28.33 | N/A |
| AVG Volume (30 Days) | ★ 272.3K | 83.6K |
| Earning Date | 11-07-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.19% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $315,549,000.00 | N/A |
| Revenue This Year | $16.84 | N/A |
| Revenue Next Year | $9.74 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.61 | N/A |
| 52 Week Low | $14.57 | $14.36 |
| 52 Week High | $31.04 | $18.88 |
| Indicator | FLGT | EOI |
|---|---|---|
| Relative Strength Index (RSI) | 45.89 | 48.58 |
| Support Level | $26.69 | $19.47 |
| Resistance Level | $31.04 | $19.79 |
| Average True Range (ATR) | 0.74 | 0.23 |
| MACD | -0.44 | 0.05 |
| Stochastic Oscillator | 9.29 | 71.05 |
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
Eaton Vance Enhanced Equity Income Fund offers mutual funds that invest across a wide array of equity, income, and alternative strategies. The primary investment objective of the fund is to provide current income, with a secondary objective of capital appreciation. The company's sector allocation includes: Information Technology, Communication Services, Financials, Consumer Discretionary, Healthcare, Industries, Consumer Staples, Energy, Real Estate, and Materials.